Graham W. Slack

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Nathalie A. Johnson, Graham W. Slack, Kerry J. Savage et al. · Journal of Clinical Oncology · 2012 · 973 citations

Medicine, Cancer Biology, Oncology +13

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Shimin Hu, Zijun Y. Xu‐Monette, Alexandar Tzankov et al. · Blood · 2013 · 679 citations · Full text

Medicine, Cancer Biology, Oncology +15

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Daisuke Ennishi, Aixiang Jiang, Merrill Boyle et al. · Journal of Clinical Oncology · 2018 · 420 citations

Medicine, Hematology, Oncology +17

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

David W. Scott, Anja Mottok, Daisuke Ennishi et al. · Journal of Clinical Oncology · 2015 · 406 citations · Full text

Medicine, Oncology, Pathology +17

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma

David D. W. Twa, Fong Chun Chan, Susana Ben‐Neriah et al. · Blood · 2014 · 297 citations

Medicine, Molecular Genetics, Oncology +16